Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.39 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.35 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.35 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13550088 | 0.86 | RAPGEF4 (0.43) | ALDH1A1RAPGEF4CYP3A4CHRM1ALOX15 | |
| SCHEMBL3930536 | 0.86 | RAPGEF4 (0.39) | ALDH1A1ALDH2ALDH3A1RAPGEF4TSHR | |
| SCHEMBL29363465 | 0.86 | RAPGEF4 (0.39) | ALDH1A1ALDH2ALDH3A1RAPGEF4TSHR | |
| SCHEMBL21614390 | 0.82 | SELL (0.46) | ALDH1A1TSHRCYP3A4CHRM1ALOX15 | |
| SCHEMBL1494527 | 0.82 | ALDH1A1 (0.38) | ALDH1A1ALDH2ALDH3A1TSHRCYP3A4 | |
| SCHEMBL24172087 | 0.82 | ALDH1A1 (0.33) | ALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL16860564 | 0.82 | ALDH1A1 (0.33) | ALDH1A1ALDH2ALDH3A1RAPGEF4MYC | |
| SCHEMBL14500126 | 0.78 | ACHE (0.48) | ALDH1A1MEN1KMT2AMAPK1KDM4E | |
| SCHEMBL7765925 | 0.75 | MYC (0.53) | ALDH1A1TSHRCYP3A4GPR35KDM4E | |
| SCHEMBL22232253 | 0.73 | GPR35 (0.52) | ALDH1A1TSHRCYP3A4ALOX15GPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4168418-B1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2026-05-27 | — | — | EP | disclosed |
| US-20260137699-A1 | OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF | GENENTECH, INC. (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260138956-A1 | NOVEL COMPOUNDS AND USES THEREOF | RECURSION PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12435099-B2 | Organic molecules for optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-10-07 | — | — | US | disclosed |
| CN-120136909-A | Boron nitride compound and application thereof | 阜阳欣奕华新材料科技股份有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-115812074-B | Organic molecules for optoelectronic devices | 三星显示有限公司 | 2025-06-13 | — | — | CN | disclosed |
| US-20250101047-A1 | BORON-NITROGEN COMPOUNDS AND ORGANIC ELECTRONIC DEVICES INCLUDING THE SAME | SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2025-03-27 | — | — | US | disclosed |
| CN-114181235-B | Polycyclic compound and device thereof | 北京夏禾科技有限公司 | 2024-10-15 | — | — | CN | disclosed |
| US-12065454-B2 | Organic molecules for optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-08-20 | — | — | US | disclosed |
| US-20240228512-A1 | ACYCLIC OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF | GENENTECH, INC. (US) | 2024-07-11 | — | — | US | disclosed |
| US-20130131042-A1 | SPIROXAZOLIDINONE COMPOUNDS | MERCK SHARP & DOHME CORP. (US) | 2013-05-23 | — | — | US | disclosed |
| EP-2571356-A1 | SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS | Merck Sharp & Dohme Corp. (US) | 2013-03-27 | — | — | EP | disclosed |
| US-20130040978-A1 | SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS | MERCK SHARP & DOHME CORP | 2013-02-14 | — | — | US | disclosed |
| US-20120225899-A1 | Compounds and Compositions as Protein Kinase Inhibitors | NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) | 2012-09-06 | — | — | US | disclosed |
| US-8242260-B2 | Compounds and compositions as protein kinase inhibitors | NOVARTIS AG (CH) | 2012-08-14 | — | — | US | disclosed |
| EP-2470528-A1 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | Novartis AG (CH) | 2012-07-04 | — | — | EP | disclosed |
| WO-2012024183-A1 | SPIROXAZOLIDINONE COMPOUNDS | MERCK SHARP & DOHME CORP. (US) | 2012-02-23 | — | — | WO | disclosed |
| WO-2011146324-A1 | SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2011-11-24 | — | — | WO | disclosed |
| US-20110052578-A1 | Compounds and Compositions as Protein Kinase Inhibitors | NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) | 2011-03-03 | — | — | US | disclosed |
| WO-2011023773-A1 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | NOVARTIS AG (CH) | 2011-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138956-A1 | NOVEL COMPOUNDS AND USES THEREOF | SLC10A1, NR3C2, CYP2C8 | ALDH1A1 230/4885ALDH2 1172/4885ALDH3A1 419/4885 |
| US-20250101047-A1 | BORON-NITROGEN COMPOUNDS AND ORGANIC ELECTRONIC DEVICES INCLUDING THE SAME | OR10J3, ETV6, ESR1 | ALDH1A1 2530/4885ALDH2 3332/4885ALDH3A1 4001/4885 |
| US-20110052578-A1 | Compounds and Compositions as Protein Kinase Inhibitors | RAF1, BRAF, ARAF | ALDH1A1 3869/4885ALDH2 4422/4885ALDH3A1 4026/4885 |
| US-12435099-B2 | Organic molecules for optoelectronic devices | OR10J3, ORC3, C5 | ALDH1A1 2489/4885ALDH2 1817/4885ALDH3A1 816/4885 |
| US-20260137699-A1 | OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF | SCN1B, OXER1, NR3C2 | ALDH1A1 970/4885ALDH2 2639/4885ALDH3A1 1386/4885 |
| US-12065454-B2 | Organic molecules for optoelectronic devices | OR10J3, OR51E2, AOX1 | ALDH1A1 219/4885ALDH2 662/4885ALDH3A1 1114/4885 |
| US-20240228512-A1 | ACYCLIC OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF | AZI2, HDAC5, HDAC4 | ALDH1A1 362/4885ALDH2 274/4885ALDH3A1 474/4885 |
| US-20120225899-A1 | Compounds and Compositions as Protein Kinase Inhibitors | RAF1, BRAF, ARAF | ALDH1A1 3869/4885ALDH2 4422/4885ALDH3A1 4026/4885 |
| US-20130131042-A1 | SPIROXAZOLIDINONE COMPOUNDS | SSTR5, SSTR2, SSTR4 | ALDH1A1 1467/4885ALDH2 816/4885ALDH3A1 1527/4885 |
| US-20130040978-A1 | SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS | SSTR5, SSTR2, SSTR1 | ALDH1A1 1103/4885ALDH2 727/4885ALDH3A1 842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.